New Knowledge About Old Drugs: The Anti-Inflammatory Properties of Cardiac Glycosides
Authors:
- 15 March 2017
- journal article
- review article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 83 (12/13) , 977-984
Abstract
In the 19th century, cardio-active steroid glycosides, shortly cardiac glycosides, were scientifically established as drugs against heart failure. Their in vivo, cellular, and molecular actions as well as their predominant target, Na+-K+-ATPase, have been comprehensively investigated in the 20th century and the discovery of endogenous cardiac glycosides has fostered this research field. In the last years, however, results from clinical trials and meta-analyses have questioned their therapeutic value due to efficacy and safety issues. This has led to a considerable decline of their usage. Beyond the cardiovascular system, cardiac glycosides have been increasingly recognized as antitumor compounds and Na+-K+-ATPase has evolved into a promising drug target in oncology. A wealth of review articles exists that intensively discuss these topics. Surprisingly, the anti-inflammatory actions of cardiac glycosides, which were discovered in the 1960s, have so far hardly been perceived and have not yet been summarized. This review provides an overview of the in vivo and in vitro actions of cardiac glycosides on inflammatory processes and of the signaling mechanisms responsible for these effects: cardiac glycosides have been found to decrease inflammatory symptoms in different animal models of acute and chronic inflammation. Regarding the underlying mechanisms most research has focused on leukocytes. In these cells, cardiac glycosides primarily inhibit cell proliferation and the secretion of proinflammatory cytokines. * Part of the special issue dedicated to Professor Max Wichtl.Keywords
This publication has 61 references indexed in Scilit:
- Endogenous Digitalis-Like Factors: An Overview of the HistoryFrontiers in Endocrinology, 2015
- Identification and characterization of a ouabain-like compound from human plasma.Proceedings of the National Academy of Sciences, 1991
- Effects of an endogenous ouabainlike compound on heart and aorta.Hypertension, 1991
- Isolation of a urinary digitalis-like factor indistinguishable from digoxinBiochemical and Biophysical Research Communications, 1990
- Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.Circulation, 1989
- Purification and characterization of human urine-derived digitalis-like factorBiochemical and Biophysical Research Communications, 1988
- Endogenous sodium pump inhibitors: A role in essential hypertension?Clinical Science, 1987
- The search for a hypothalamic Na+,K+-ATPase inhibitor.Hypertension, 1987
- Endogenous Digitalis-like Factor or FactorsNew England Journal of Medicine, 1987
- Introduction and Remarks on the History of Cardiac Glycosides1981